The years between 2010 and 2020 may likely be remembered as the decade of gene therapy, and perhaps, the end of cancer, heart disease, blindness, deafness, and even aging – if this revolutionary technology is properly implemented and integrated into our healthcare infrastructure. But it will not happen without effort, or even without a fight – for gene therapy threatens to undermine and overturn some of the largest and most influential corporate monopolies on Earth.
Gene Therapy is Already a Working “Miracle Cure”
In 2012, at the age of six years old, Emily Whitehead was enrolled in a phase I clinical trial at Children’s Hospital of Philadelphia to treat her acute lymphoblastic leukemia (ALL). She had failed to respond to all other treatments.
The clinical trial involved removing and genetically regineering her immune system’s T-cells. Using viruses as a vector to insert new DNA into her T-cells, they were…
View original post 1,546 more words